These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 29392424)
1. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL). Shahkarami S; Mehrasa R; Younesian S; Yaghmaie M; Chahardouli B; Vaezi M; Rezaei N; Nikbakht M; Alimoghaddam K; Ghavamzadeh A; Tavakkoly-Bazzaz J; Ghaffari SH Ann Hematol; 2018 Apr; 97(4):585-595. PubMed ID: 29392424 [TBL] [Abstract][Full Text] [Related]
2. Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye. Li AH; Forestier E; Rosenquist R; Roos G Exp Hematol; 2002 Oct; 30(10):1170-7. PubMed ID: 12384148 [TBL] [Abstract][Full Text] [Related]
3. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Garand R; Beldjord K; Cavé H; Fossat C; Arnoux I; Asnafi V; Bertrand Y; Boulland ML; Brouzes C; Clappier E; Delabesse E; Fest T; Garnache-Ottou F; Huguet F; Jacob MC; Kuhlein E; Marty-Grès S; Plesa A; Robillard N; Roussel M; Tkaczuk J; Dombret H; Macintyre E; Ifrah N; Béné MC; Baruchel A Leukemia; 2013 Feb; 27(2):370-6. PubMed ID: 23070018 [TBL] [Abstract][Full Text] [Related]
5. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring. Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245 [TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements. Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341 [TBL] [Abstract][Full Text] [Related]
7. [Real-time quantitative study of minimal residual disease in childhood B cell acute lymphoblastic leukemia]. Jia YP; Liu GL; Zhang LP Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):600-4. PubMed ID: 15347448 [TBL] [Abstract][Full Text] [Related]
8. Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia. Šálek C; Folber F; Froňková E; Procházka B; Marinov I; Cetkovský P; Mayer J; Doubek M; Eur J Haematol; 2016 Mar; 96(3):276-84. PubMed ID: 25997106 [TBL] [Abstract][Full Text] [Related]
9. [Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection]. Yao L; Chen ZX; Cen JN; Liu H; He J; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):433-7. PubMed ID: 21122394 [TBL] [Abstract][Full Text] [Related]
10. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]. zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545 [TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients. Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752 [TBL] [Abstract][Full Text] [Related]
12. An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia. Nunes V; Cazzaniga G; Biondi A Expert Rev Mol Diagn; 2017 Nov; 17(11):953-963. PubMed ID: 28891364 [TBL] [Abstract][Full Text] [Related]
17. [Detection of minimal residual disease in childhood acute lymphoblastic leukemia by using real-time quantitative PCR]. Zhang YT; Luo ZF; Fang JP; Guo HX; Huang K; Li CK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1235-9. PubMed ID: 21129267 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies. Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599 [TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease detection using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Slovak experience. Kolenova A; Hikkel I; Ilencikova D; Hikkelova M; Sejnova D; Kaiserova E; Cizmar A; Puskacova J; Bubanska E; Oravkinova I; Gencik M Neoplasma; 2010; 57(6):552-61. PubMed ID: 20845994 [TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]